Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.9B | 2.8B | 2.7B | 2.6B |
Cost of revenue | 1.3B | 1.3B | 1.3B | 1.2B |
Gross profit | 1.6B | 1.5B | 1.4B | 1.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.3B | 1.1B | 1.1B | 1.1B |
Operating income | 250.7M | 295.2M | 283.2M | 274.6M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 55.0M | 48.7M | 50.1M | 45.5M |
Other income expense | — | — | — | — |
Pretax income | 205.3M | 250.8M | 235.2M | 233.7M |
Tax provision | 13.4M | 41.6M | 38.6M | 34.3M |
Net income | 192.0M | 209.2M | 196.6M | 199.4M |
Basic EPS | — | 2.2 | 2.1 | 2.1 |
Diluted EPS | — | 2.2 | 2.1 | 2.1 |
Basic average shares | — | 96.4M | 95.4M | 97.3M |
Diluted average shares | — | 96.4M | 95.4M | 97.3M |
EBITDA | 302.1M | 343.9M | 326.8M | 320.8M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |